Study Stopped
Retrospective record review only (no subject enrollment). Contract never executed between Sponsor and Site.
DePuy Revision TKA Implant 5yr Survivorship
Clinical Outcome and 5-year Implant Survival Rate Among Adult Revision Total Knee Arthroplasty Patients With DePuy Implant Components
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
This will be a retrospective chart review of 200 charts of adult patients who have undergone a revision TKA at New England Baptist Hospital and who received implant component(s) manufactured by DePuy Orthopedics. The data will be collected retrospectively after patients are seen clinically for a minimum of five years after surgery to answer:
- 1.What is the five-year survivorship of revision a knee prosthesis containing components manufactured by DePuy Orthopedics among adult revision TKA patients?
- 2.What patient factors are associated with the need for re-operation after revision TKA among patients receiving DePuy implant components? How do clinical outcomes change from baseline over the five-year follow-up after revision TKA surgery?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2010
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 19, 2010
CompletedFirst Posted
Study publicly available on registry
November 22, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedMay 1, 2013
April 1, 2013
1.7 years
November 19, 2010
April 30, 2013
Conditions
Keywords
Eligibility Criteria
Any NEBH patients who received DePuy implant components during a Revision TKA procedure, performed by either: * Dr. Geoffrey Van Flandern * Dr. David Mattingly * Dr. James Nairus * Dr. James Bono * Dr. Daniel Ward * Dr. Carl Talmo
You may qualify if:
- Received a Revision TKA (must have been initial revision)
- Received J\&J/DePuy implant components for initial revision
- Procedure performed at New England Baptist Hospital
You may not qualify if:
- nd Revision TKA on knee
- Received femoral or tibial components not of DePuy manufacture
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The New England Baptist Hospitallead
- Depuy, Inc.collaborator
Study Officials
- PRINCIPAL INVESTIGATOR
John Richmond, MD
New England Baptist Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2010
First Posted
November 22, 2010
Study Start
November 1, 2010
Primary Completion
July 1, 2012
Study Completion
July 1, 2012
Last Updated
May 1, 2013
Record last verified: 2013-04